trending Market Intelligence /marketintelligence/en/news-insights/trending/ylkfg_qxg1-fmydjvg7zya2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Oryzon Genomics adds Synlogic CEO to board

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

Blog

Corporate Credit Risk Trends in Developing Markets: A Probability of Default Perspective


Oryzon Genomics adds Synlogic CEO to board

Barcelona, Spain-based Oryzon Genomics SA added José Gutiérrez-Ramos to the company's board as an independent director.

Gutiérrez-Ramos is the president and CEO of Synlogic Inc.

Meanwhile, three directors representing Najeti, a private investment fund that owns 20.54% of Oryzon's capital, have resigned from the company's board.

Following the changes, Oryzon's board is now composed of seven directors, with four as independent directors.

Oryzon develops therapies for cancer and neurodegenerative diseases.